论文部分内容阅读
涨升空间大幅下降,盈利动能有所下降是爱尔眼科被剔除出I66的主要原因。分析师给出的12个月综合目标价为25.91元,涨升空间仅为9.79%;近一周内国联证券将其2011年盈利预测由0.68元调低至0.42元。
Rising space fell sharply, earnings decline in kinetic energy is Ireland’s eye was removed from the main reason I66. Analysts given a 12-month target price of 25.91 yuan, an increase of only 9.79% space; nearly a week within the Allianz Securities 2011 earnings forecast from 0.68 yuan to 0.42 yuan.